Showing results (41-50 of 192) with videos related to
Sort By:
Pageof 20
Journal of Geriatric Oncology|February 9, 2016
A prospective study examining elder-relevant outcomes in older adults with prostate cancer undergoing treatment with chemotherapy or abirateroneTharsika Manokumar, Salman Aziz, Henriette Breunis, et al.Nature Reviews. Clinical Oncology|February 21, 2019
Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.Oncology Letters|February 20, 2016
Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanomaLeila Khoja, Eshetu G Atenafu, Qian Ye, et al.British Journal of Cancer|October 5, 2016
Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patientsLeila Khoja, Minnie Kibiro, Ur Metser, et al.Journal of Clinical Pathology|July 3, 2019
Developing a pan-cancer research autopsy programmePrashant Bavi, Madura Siva, Tarek Abi-Saab, et al.Clinical Genitourinary Cancer|March 18, 2015
Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerJo-An Seah, Raya Leibowitz-Amit, Eshetu G Atenafu, et al.Neoplasia (New York, N.Y.)|July 6, 2006
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangementMaisa Yoshimoto, Anthony M Joshua, Susan Chilton-Macneill, et al.Journal of Geriatric Oncology|October 11, 2014
Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancerRaya Leibowitz-Amit, Arnoud J Templeton, Shabbir M Alibhai, et al.Investigational New Drugs|December 19, 2017
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancerEvan Y Yu, Susan L Ellard, Sebastien J Hotte, et al.Cancer Genetics and Cytogenetics|August 30, 2006
Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasiasMaisa Yoshimoto, Jean-Claude Cutz, Paulo A S Nuin, et al.Pageof 20